Navigation Links
New Compound Offers Hope In Liver Cancer Treatment

The identification of a novel compound, CDDO-Im, shown to possess strong anti-tumor properties in studies conducted on animal models could soon revolutionize the treatment of liver cancer patients. // The compound has been found to increase the intrinsic resistance to carcinogens (cancer causing substances) by enhancing the function of enzymes that remove toxins from the body. Further results about the compound have been published in the journal Cancer Research.

The compound has been found to be active (100 times effective than other anti-tumor compounds) at very small doses. It is hoped that the compound could play an important role in the prevention of cancers associated with inflammation such as lung cancer, liver cancer, prostate cancer and gastric cancer. It can also help in the treatment of asthma, emphysema or other neurodegenerative disorders, linked to inflammation.

The synthetic compound, a derivative of oleanolic acid, belongs to a class of compounds commonly referred to as triterpenoids. Previous studies have established the anti-tumor properties of oleanolic derivatives in animals and humans.

In order to assess the effectiveness of cancer prevention, the researchers treated rats with aflatoxin, a carcinogen, known to cause liver cancer. The rates were treated with 0.1, 0.3, 1.0, 3.0 or 10 micromole doses of CDDO-Im. As much as 85% reduction in the incidence of pre-cancerous lesions could be observed when rats were treated with 0.1 mmol of the compound. This anti-cancer property could be due to associated activation of Nrf2 protein. This protein is believed to play a major role in the protection of body against environmental toxins.

The results of this study have several important clinical applications. First, it could lead to the development of new cancer prevention strategies. Second, it can attenuate the clinical features and provide relief to those suffering from inflammatory diseases. Third, it can pro tect humans from several diseases that can be attributed to a specific environmental agent.


'"/>




Related medicine news :

1. Compound of Broccoli combats breast cancer
2. New Compound Could Strengthen The Effect Of Chemotherapy
3. Breathing Cancer Causing Compounds During Pregnancy Found To Affect Offspring
4. Compound from cottonseed for neck and head cancers
5. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
6. Adding Sorghum Compounds To Dietary Supplements May Help Lower Cholesterol
7. Compound In Grapes And Red Wine To Counter Alzheimers Disease
8. Sugars Could Contain Key Cancer Inhibiting Compounds
9. Compound From Cyanobacterium Can Fight Alzheimer’
10. Five New Anti-Inflammatory Compounds Produced By Indian Scientists
11. Compounds in Licorice Can Fight Tooth Decay
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... 21, 2017 , ... West Dermatology is pleased to announce the newest addition ... 2017, Ms. Vu will join West Dermatology’s large network of medical and cosmetic dermatology ... cancer , and more. She graduated from the University of Florida College of Medicine ...
(Date:7/20/2017)... ... July 20, 2017 , ... TransPixel Volume 2 is a set ... the FCPX timeline. This effect isolates horizontal and vertical lines of pixels and sorts ... a rotating or flipping animation and can be changed using a drop-down menu. Create ...
(Date:7/20/2017)... ... July 20, 2017 , ... Coats Rose, P.C. , ... announce their expansion to the Midwest with the establishment of the firm’s new ... Bell, and of counsels, John Peck and Robert Bruns, will establish and anchor ...
(Date:7/20/2017)... ... July 20, 2017 , ... Doctors on Liens, the leading network of ... Chiropractic , directed by Dr. Russell Horine, DC to their exclusive list of medical ... Dr. Russell Horine serving as the clinic director and his son Dr. Lee Horine ...
(Date:7/20/2017)... ... 2017 , ... The Dermatology Clinic announced today the addition of Dr. Scott ... from LSU, graduating summa cum laude. He attended Emory University School of Medicine in ... Louis, Dr. Dunbar moved to New York to complete an AGCME-accredited Mohs surgery fellowship ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... July 5, 2017 Pace Analytical, a company of over 2,000 employees ... they have acquired ESC Lab Sciences, further solidifying their position as the top ... . ... President and CEO of Pace Analytical ... Sciences out of Mt Juliet, TN , enhances Pace Analytical,s ...
(Date:6/30/2017)... June 30, 2017 In vitro diagnostics market ... of May, at least ten diagnostic companies have successfully ... public offerings and a loan facility.  The size of ... $80 million.  Kalorama Information provides a monthly IVD ... Diagnostics Knowledge Center. ...
(Date:6/27/2017)... June 27, 2017  Therapix Biosciences Ltd. (Nasdaq: ... specializing in the development of cannabinoid-based drugs, today announced ... Opening Bell in New York, NY ... its initial public offering (IPO) of American Depository Shares ... 2017. Dr. Elran Haber, Ph.D., Chief Executive ...
Breaking Medicine Technology: